Market capitalization | $13.56m |
Enterprise Value | $13.73m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 33.49 |
EV/Sales (TTM) EV/Sales | 0.68 |
P/S ratio (TTM) P/S ratio | 0.67 |
P/B ratio (TTM) P/B ratio | 2.49 |
Dividend yield | 9.13% |
Last dividend (FY22) | $0.21 |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
1 Analyst has issued a forecast Psychemedics Corporation:
1 Analyst has issued a forecast Psychemedics Corporation:
Sep '24 |
+/-
%
|
||
Revenue | 20 20 |
11%
11%
|
|
Gross Profit | 7.77 7.77 |
10%
10%
|
|
EBITDA | -0.69 -0.69 |
253%
253%
|
EBIT (Operating Income) EBIT | -2.93 -2.93 |
22%
22%
|
Net Profit | -3 -3 |
23%
23%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. It specializes in a five panel drug testing process for cocaine, opioids, Phenyclidine, amphetamines, and marijuana. It offers workplace, school, and personal drug testing services. The company was founded by Werner Baumgartner and Annette Baumgartner on September 24, 1986 and is headquartered in Acton, MA.
Head office | United States |
CEO | Brian Hullinger |
Employees | 116 |
Founded | 1986 |
Website | www.psychemedics.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.